Fig. 1From: Risk definition and outcomes with the application of the PEGASUS-TIMI 54 trial inclusion criteria to a “real world” STEMI population: results from the Italian “CARDIO-STEMI SANREMO” registryKaplan–Meier analysis of 4-year survival for PG-l versus non-PG-l patientsBack to article page